Filter Results:
(342)
Show Results For
- All HBS Web
(578)
- People (4)
- News (144)
- Research (342)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(578)
- People (4)
- News (144)
- Research (342)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Sort by
- 11 May 2010
- First Look
First Look: May 11
rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards View Details
Keywords: Martha Lagace
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
structure the background against which business operates. The aim is to develop a plausible framework for managerial decision-making that respects the fact of value pluralism in a global economy and that fosters meaningful criticism of... View Details
Keywords: Sean Silverthorne
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
fruitful new agendas for research on the political-economic nexus as it has developed in the Western world since the end of the Middle Ages. New Perspectives on the History of Political Economy brings together a select group of young and... View Details
Keywords: Sean Silverthorne
- 30 Oct 2007
- First Look
First Look: October 30, 2007
in the multi-agent settings in which these decisions typically occur. In this paper, we develop a model that extends neural nets techniques to capture recognition processes in groups of decision-makers. We use the model to derive some... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular... View Details
Keywords: Martha Lagace
- 08 Jun 2010
- First Look
First Look: June 8
decisions to employees further down the managerial hierarchy. Economists have developed a range of theories to account for delegation, but there is less empirical evidence, especially across countries. This has limited the ability to... View Details
Keywords: Martha Lagace
- 29 Jan 2021
- Op-Ed
How Influencers, Celebrities, and FOMO Can Win Over Vaccine Skeptics
vaccination efforts. In contrast to the product-centric view employed to develop and distribute the vaccines, the shots-in-arms problem of convincing people to be vaccinated requires patient- or customer-centric solutions. [div... View Details
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
dropped. Similar situations have transpired with the advent of digitized photography, use of radio frequencies for various handheld IT appliances, and the development of such products as elevators that call in to the service center or to... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from... View Details
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing View Details
Keywords: Carmen Nobel
- 24 May 2011
- First Look
First Look: May 24
and further development of the original cluster framework. The fourth part then explores the policy implications to be drawn from Porter's work on clusters. Porter develops recommendations on how to leverage... View Details
Keywords: Sean Silverthorne
- 23 Aug 2016
- First Look
August 23, 2016
science education from around the world as they discuss regional trends and models, with a specific focus on developments in and cooperation with China. Focusing on why this model responds to the twenty-first century requirements for... View Details
Keywords: Sean Silverthorne
- 15 Jan 2013
- First Look
First Look: January 15
company was hurt by long delays in bringing Bydureon, a once-a-week version of Byetta, to market, which allowed a competitor time to establish itself in the once-a-week market. Amylin also failed to develop a marketable anti-obesity View Details
Keywords: Sean Silverthorne
- 31 Jan 2017
- First Look
First Look at New Research: January 31, 2017
Abstract—The Food and Drug Administration approves new medical devices after in-depth reviews of safety and effectiveness data. Some have advocated for shorter review times to encourage innovation. We evaluated whether regulatory review... View Details
Keywords: Carmen Nobel
- 08 Nov 2016
- First Look
November 8, 2016
and models, with a specific focus on developments in and cooperation with China. Focusing on why this model responds to the twenty-first century requirements for excellence and relevance in undergraduate education, contributors examine if... View Details
Keywords: Sean Silverthorne
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
said. The potential influence on drug development in particular, and medicine in general, is enormous, panelists agreed. Today's drugs can reach some 400 to 500 potential... View Details
Keywords: by Sean Silverthorne
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require... View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
pharmaceuticals, it concentrated on enlarging its OTC business by, as before, exploiting its advertising skills. By 1979 it had developed a broader line of new prescription drugs, beginning in 1968 with Inderal, a beta-blocker View Details
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the 1990s, the U.S. and European... View Details